Purchase Order 75D30123P17495
Award Date
9/1/23
Potential Completion Date
9/28/23
Potential Value
$17K
Federal Agency
CDC Pittsburgh
Awardee
Quest Diagnostics Incorporated
Ultimate Awardee
Quest Diagnostics Incorporated
NAICS Category
621511 - Medical Laboratories
PSC Category
6509 - Drugs And Biologicals, Veterinary Use
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Halethorpe, MD 21227, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Centers for Disease Control and Prevention awarded a firm-fixed price contract valued at $1,676,070.04 to Quest Diagnostics Clinical Laboratories, Inc. to meet requirements established in a January 2020 solicitation. The solicitation sought longitudinal laboratory test order and result data for hosting in CDC's Data Hub to support analyses of public health trends related to reportable diseases and exposures over time. Only Quest could fulfill this requirement due to its market share and...
Quest Diagnostics Incorporated has been awarded a firm fixed price, definitive contract valued at twenty-one million, seven hundred ninety-five thousand, twenty-six dollars by the Centers for Disease Control and Prevention to provide MASS-C serology services. Performance will take place in Secaucus, New Jersey with a completion date of December 11, 2023. No set-aside designation was used for this solicitation. As a leading provider of diagnostic information services, Quest Diagnostics will...
The Centers for Disease Control and Prevention (CDC) awarded a $14 million firm fixed price delivery order contract to Quest Diagnostics Incorporated for surge serology testing services. Under the contract, Quest Diagnostics will provide COVID-19 antibody testing from its laboratory located in Secaucus, New Jersey to support the CDC's pandemic response efforts. The period of performance is from July 30, 2020 through November 19, 2020. No set aside designation or subcontractors were identified....
This is a $24,691,200 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Incorporated for serology testing services. The contract has a period of performance through March 5, 2022 and was awarded on November 13, 2020 without any set-aside designation. Quest Diagnostics, a for-profit diagnostic information services provider, has previously supported federal agencies such as the Department of Justice's Bureau of Prisons, the...
This federal contract award, with an ID of 75D30124P19524, was issued by the Centers for Disease Control and Prevention (CDC) Pittsburgh office to Quest Diagnostics Incorporated, a leading provider of clinical laboratory services. The $93,600.00 firm fixed-price contract is for the delivery of de-identified nasopharyngeal specimens to support the CDC's public health research initiatives. The contract has an ultimate completion date of August 13, 2026 and was awarded on August 14, 2024 without...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Clinical Laboratories, Inc., a subsidiary of Quest Diagnostics Incorporated, for $92,922.00 in laboratory services. The contract is for the provision of comprehensive diagnostic testing solutions, including drug and alcohol testing, COVID-19 testing, and specialized diagnostic analyses, to support various federal healthcare, law enforcement, and workplace safety...
This is a $4,470,182.84 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Incorporated, a provider of diagnostic information services. The contract is for "QUEST DIAGNOSTICS DATA" and has a period of performance through March 3, 2025. Quest Diagnostics has previously provided COVID-19 and other infectious disease testing services, as well as reference laboratory testing support, to various federal agencies...
This contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Quest Diagnostics Incorporated, a for-profit diagnostic information services provider, for data submission services. The contract is a definitive, firm fixed-price contract with a potential value of $722,500.00. The purpose is to obtain laboratory test order and test result data, including longitudinal patient identifiers but without personally identifiable information, to...
This firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Quest Diagnostics Incorporated, doing business as Quest Diagnostics, for a Hepatitis C Prevalence Study. The $1,992,000.00 contract is to conduct a cross-sectional, multi-state assessment of viral hepatitis C prevalence through commercial laboratory testing of stored serum specimens, with a period of performance from September 2023 to September 2024. Quest Diagnostics has provided...
The Centers for Disease Control and Prevention (CDC) awarded a $728,000 firm fixed price definitive contract to Quest Diagnostics Incorporated for de-identified specimen remnants to support the National Center for Immunization and Respiratory Diseases (NCIRD). As the prime contractor, Quest Diagnostics will provide de-identified biological specimens to NCIRD through April 2021. No subcontractors or set aside designations were indicated. NCIRD conducts public health surveillance, laboratory...